Additional Information
Short Description: |
Activator of DREADDs |
Research Area: |
Cell Signaling, G Protein Signaling, GPCR, Neuroscience, Neurotransmission |
Alternative Name(s): |
8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
Category: |
Small Molecules |
Product Type: |
Activator |
CAS No.: |
34233-69-7 |
Molecular Formula: |
C18H19ClN4O |
Molecular Weight: |
342,8 |
Source: |
Synthetic |
Purity: |
>98% (TLC); NMR (Conforms) |
Solubility: |
May be dissolved in DMSO (15 mg/ml); or ethanol (3 mg/ml) |
Appearance: |
Yellow powder |
Storage: |
-20ºC |
Shipping: |
Shipped Ambient |
SMILES: |
ClC(C=C3)=CC1=C3NC(C=CC=C2)=C2C(N4CC[N+](C)([O-])CC4)=N1 |
InChI: |
InChI=1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3 |
InChIKey: |
WYRDWWAASBTJLM-UHFFFAOYSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
Clozapine N-oxide | B1925
26
NULL1,084.00
Clozapine N-oxide is a metabolite of clozapine that activates human muscarinic designer receptors (DREADDs) in vitro.Clozapine N-oxide is a metabolite of clozapine that activates human muscarinic...
26-B1925-GEN
